InvestorsHub Logo
Followers 14
Posts 649
Boards Moderated 0
Alias Born 04/03/2014

Re: None

Wednesday, 10/28/2015 1:52:38 PM

Wednesday, October 28, 2015 1:52:38 PM

Post# of 461833
Wanted to mention , I have noticed for quite a while that some very knowledgable investors are very bullish on 273 for epilepsy.. I have been aware that Anavex pre-clinical epilepsy results were stellar, but even still, their huge bullishness still made me wonder if I was missing something... Well today I found I had in fact missed something significant....and that was that the only other recent sigma 1 agonist to target epilepsy in pre-clinical trials also had stellar results -- being CNCE.... From that it appears 273 for epilepsy is a slam dunk... However, knowing how positive and overwhelming Epilepsy pre-clinicals were they still went for AD.....and what does that tell you about what they thought of AD's chances for success....Wow... and with an apparent slam dunk in epilepsy waiting in the wing...
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News